Increased cerebral blood flow after leukapheresis for acute myelogenous leukemia

American Journal of Hematology

Volumn 82, Issue 12, 2007, Pages 1110-1112

  Kasner, Margaret T ^a   Laury, Adrienne ^a   Kasner, Scott E ^a   Carroll, Martin ^a   Luger, Selina M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CYTARABINE; ETOPOSIDE; GADOLINIUM; HYDROXYUREA; IDARUBICIN; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANAMNESIS; ARTICLE; BONE MARROW BIOPSY; BRAIN BLOOD FLOW; BRAIN INFARCTION; CANCER CHEMOTHERAPY; CASE REPORT; CEREBRAL ARTERY DISEASE; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DOPPLER ECHOGRAPHY; DRUG MEGADOSE; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HUMAN TISSUE; LABORATORY TEST; LEUKAPHERESIS; MENINGIOMA; MONOTHERAPY; MORTALITY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STROKE; TREATMENT OUTCOME;

BLOOD FLOW VELOCITY; BRAIN; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; LEUKAPHERESIS; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTE COUNT; MENINGIOMA; MIDDLE AGED;

EID: 36749098991     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21006     Document Type: Article

References (14)

1. Glidewell O, Holland JF. Comparative prognosis of the acute leukemias. Bibl Haematol 1975:527-530.
2. Ventura GJ, Hester JP, Smith TL, et al. Acute myeloblasts leukemia with hyperleukocytosis: Risk factors for early mortality in induction. Am J Hematol 1988;27:34-37.
3. Estey EH, Keating MJ, McCredie KB, et al. Causes of initial remission induction failure in acute myelogenous leukemia. Blood 1982;60:309-315.
4. Lichtman MA, Heal J, Rowe JM. Hyperleukocytic leukaemia: Rheological and clinical features and management. Baillieres Clin Haematol 1987;1:725-746.
5. Rogers LR. Cerebrovascular complications in cancer patients. Neurol Clin 2003;21:167-192.
6. Cuttner J, Holland JF, Norton L, et al. Therapeutic leukapheresis for hyperleukocytosis in acute myelocytic leukemia. Med Pediatr Oncol 1983;11:76-78.
7. Zarkovic M, Kwaan HC. Correction of hyperviscosity by apheresis. Semin Thromb Hemost 2003;29:535-542.
8. Sharma VK, Tsivgoulis G, Lao AY, et al. Role of transcranial doppler ultrasonography in evaluation of patients with cerebrovascular disease. Curr Neurol Neurosci Rep 2007;7:8-20.
9. Vecsei PV, Kircher K, Egger S, et al. Color doppler ultrasound investigation of the therapeutic effect of plasmapheresis on a lymphoplasmocytoid lymphoma (immunocytoma): A case of central retinal artery occlusion. Ann Hematol 1996;73:29-32.
10. Demchuk AM, Saqqur M, Alexandrov AV. Transcranial doppler in acute stroke. Neuroimaging Clin N Am 2005;15:473-480,ix.
11. Heye S, Maleux G, Van Loon J, et al. Symptomatic stenosis of the cavernous portion of the internal carotid artery due to an irresectable medial sphenoid wing meningioma: Treatment by endovascular stent placement. AJNR Am J Neuroradiol 2006;27:1532-1534.
12. Shaffrey ME, Dolenc VV, Lanzino G, et al. Invasion of the internal carotid artery by cavernous sinus meningiomas. Surg Neurol 1999;52:167-171.
13. Dohner K, Schlenk RF, Habdank M, et al. Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: Interaction with other gene mutations. Blood 2005;106:3740-3746.
14. Kawagoe H, Grosveld GC. Conditional MN1-TEL knock-in mice develop acute myeloid leukemia in conjunction with overexpression of HOXA9. Blood 2005;106:4269-4277.